This phase III, randomized, single blind (subject), active control, parallel assignment, safety/efficacy study is currently recruiting approximately 50 participants. The principal investigator of the study is Adam R Witkowski, MD,PhD Institute of Cardiology, Warsaw, Poland.
Luc-Chopin 2 is a biodegradable polymer coated, paclitaxel coronary drug eluting stent. Luc-Chopin stent coating technology enables to obtain the most flexible layer of biodegradable polymer, paclitaxel carrier. The polymer layers release paclitaxel in time-controlled process of their slow biodegradation (lasting ca 6 weeks), inhibiting neointime formation process.
